GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Quality Rank

KOAN (Resonate Blends) Quality Rank


View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Resonate Blends Quality Rank Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Resonate Blends Business Description

Traded in Other Exchanges
N/A
Address
One Marine Plaza, Suite 305A, North Bergen, NJ, USA, 04047
Resonate Blends Inc engages in the discovery, development and marketing of products designed to better mankind. The company believes It is positioning its company as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. It is focusing its current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their adult stem cells from their bone marrow.
Executives
Richard Hoge 10 percent owner C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin officer: Chief Operating Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer director, officer: Chief Executive Officer 26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen 10 percent owner, officer: COO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello 10 percent owner, officer: VP of Sales 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi director, 10 percent owner, officer: CEO 1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii director
Gregory Oliver Sargent 10 percent owner 1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester officer: Vice President 3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane other: Controller 50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley director 945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley director 2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr director 2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee officer: VP of Product Development
Jeffrey Longoria officer: VP of Sales